Bio-TT

Each dose (0.5 ml) contains: Purified tetanus toxoid 10 Lf, Aluminium phosphate (as adsorban) 1.5 mg, Thimerosal (as preservative) 0.05 mg.
BIO-TT is TT vaccine contains purified tetanus toxoid. The toxoid is adsorbed onto 3 mg/ml aluminium phosphate. Thimerosal 0.1 mg/ml is used as a preservative. One dose of 0.5 ml has a potency of at least 40 IU. TT is used in the prevention of neonatal tetanus by immunizing women of childbearing age, and also in the prevention of tetanus.

For the active immunization to produce antibody against tetanus and used in the prevention of neonatal tetanus by immunizing women of child bearing age.

The vaccine should be shaken before use to homogenize the suspension. It should be injected intramuscularly or deep subcutaneously. A sterile needle and sterile syringe should be used for each injection.
Immunization schedule: TT immunization for the prevention of tetanus/neonatal tetanus consist of two primary doses of 0.5 ml given intramuscularly or deep subcutaneously at least four weeks apart followed by the third dose 6 months later. To maintain the immunity of women against tetanus through the child bearing period, five doses are recommended. The fourth dose should be given at least one year after the third dose, and the fifth dose should be given at least one year after the fourth dose. TT immunization can be administered safely during pregnancy even during the first trimester.

A severe reaction to a previous dose of TT, hypersensitivity to any component of the vaccine, immunization should be deferred during any febrile illness or acute infection.

A minor febrile illness such as mild upper respiratory infection is not usually reason to defer immunization.

Rare and mild. Some temporary tenderness and redness at the site of the injection and occasional fever. It is safe to give during pregnancy. Allergic acute reactions, dyspnea, urticaria, angioneurotic oedema, anaphylactic and acute reaction may occur.

TT should be stored and transported between 2-8°C. DO NOT FREEZE.
Shelf-Life: 3 years.

Vaccines, Antisera & Immunologicals

J07AM01 - tetanus toxoid ; Belongs to the class of tetanus bacterial vaccines.

D